Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 2,548 people who get email alerts on PPHM.

Get email alerts on PPHM »

Market Currents

Peregrine Pharmaceuticals (PPHM) is halted with news pending. Shares rose 7.2% on Friday.

Monday, September 24, 2012, 7:06 AM ET
Peregrine Pharmaceuticals (PPHM) is halted with news pending. Shares rose 7.2% on Friday.

This Market Current was sent to 2,548 people who get email alerts on PPHM.

Get email alerts on PPHM »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin
4:43 PM • Sharon di Stefano
Benjamin Graham's Rules For The Common Stock Component: Questcor Pharmaceuticals Inc.
11:35 AM • Jarrod W. Jacinth
Vivus Taps Into More Cash
9:41 AM • Spencer Osborne
China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug
9:14 AM • ChinaBio Today
Why MannKind's Afrezza Will Succeed Where Pfizer Failed
4:45 AM • Cory Renauer
A Journey To Add Biotech To The Portfolio
2:38 AM • Gregory Stuckey
Here's Why Amgen Shares Are Worth $117 To $126 Today
1:03 AM • Stephen Barnes
Oncothyreon A Speculative Buy
8:52 PM • Northwest Trader
BioLife Has More Room To Run
6:00 PM • Brian Marckx
Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds
5:21 PM • Randy Durig
The Billion Dollar COPD Deal: Who Gains The Most?
11:27 AM • Emerging Equities
Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth
11:04 AM • StockPro2X
Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy
7:25 AM • John Tobey
AdCare Tender Offer Looks Improbable
5:45 AM • Benjamin Mackovak
Arena Outlines Belviq Launch And Goals
2:01 AM • Spencer Osborne

More Latest Articles »